Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Delisting risk
confidence 75%
filed 2026-06-29
EX-99.1
New Found Gold announces conditional approval to graduate from the TSX Venture Exchange to the Toronto Stock Exchange, with concurrent delisting from TSXV. While this is a positive corporate milestone reflecting the company's maturation, the delisting from TSXV is a material change in listing status. The disclosure explicitly states "Concurrently with the graduation to the TSX, the Company's common shares will be delisted from the TSXV," which constitutes a transfer of listing venue (Item 3.01 equivalent). This affects trading venue and liquidity for shareholders, making it material to investor assessment.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-06-29
EX-99.1
Zentek announced entry into an exclusive licensing agreement with Applied Silver Inc. dated June 26, 2026, granting rights to incorporate silver technology into ZenGUARD™ Enhanced Air Filtration Media for U.S. market commercialization across HVAC, healthcare, residential, and other applications. This is a material strategic partnership and commercialization milestone that advances the company's business strategy and market access, but does not constitute a discrete M&A transaction, debt issuance, or other specifically-named event type—it is a material operational/commercial agreement that would affect investor assessment of the company's growth prospects.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 95%
filed 2026-06-29
EX-99.1
This exhibit is a comprehensive Statement of Executive Compensation disclosing the compensation arrangements, policies, and awards for Mako Mining's named executive officers (CEO Akiba Leisman, CFO Ezequiel Sirotinsky, President Stephen Parsons, COO Jesse Munoz, and VP Exploration Frank Powell) for fiscal year 2025. It details base salaries, annual bonuses, equity-based awards (RSUs, DSUs, Options), performance metrics, and governance policies including a newly adopted clawback policy effective February 23, 2026. The Summary Compensation Table shows total compensation ranging from $676,717 to $2,623,649 across the NEOs, making this a material disclosure of executive compensation arrangements and awards.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 75%
filed 2026-06-29
EX-99.1
The exhibit announces amendments to an outstanding CAD $1.0 million convertible debenture, extending the maturity date by two years (to June 30, 2028) and reducing the conversion price from CAD $1.25 to CAD $1.00 per share. While technically an amendment rather than a new issuance, the material modification of debt terms—particularly the conversion price reduction, which increases dilution potential to 1,000,000 shares—constitutes a material financial obligation event. The warrant expiry extension is ancillary to the primary debenture amendment.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-06-29
Item 7.01
MetLife is furnishing preliminary, unaudited variable investment income estimates for Q2 2026 ($220–$270 million pre-tax) ahead of its formal earnings release scheduled for August 5, 2026. This is a financial disclosure under Item 7.01 (Regulation FD) that provides quantitative guidance on a material income component, though explicitly labeled preliminary and non-binding. The disclosure is material to investors assessing quarterly performance but does not fit the specific `earnings_release` category (which typically applies to the full audited earnings announcement); it is best classified as a financial guidance or preliminary results disclosure falling under `financial_other`.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-06-29
Item 8.01
The filing discloses multiple material capital-raising and financing activities: issuance of $800 million in senior unsecured notes on April 7, 2026 with a cross-currency swap component; replacement of the ATM program on May 7, 2026 with authorization to sell up to 150 million shares; and a detailed liquidity position as of June 25, 2026 totaling approximately $4.0 billion. These are financial events material to investors assessing the company's capital structure and liquidity, but they do not fit neatly into the specific categories of debt_issuance (which typically covers a single debt event) or dilutive_issuance (which typically covers equity sales). The filing bundles capital raising, liquidity matters, and financing updates together, making financial_other the most appropriate classification.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-06-29
EX-99.1
This press release announces a long-term supplier agreement between Vertical Aerospace and Astronics Corporation for the low-voltage power distribution system on Vertical's Valo eVTOL aircraft. The disclosure is a material operational/strategic event—it represents a significant supply-chain commitment for a critical aircraft system as Vertical advances toward certification and commercial production. While not a discrete M&A transaction, it is a material commercial arrangement that would affect a reasonable investor's assessment of Vertical's progress toward certification and production readiness.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-06-29
The filing discloses multiple material M&A activities: (1) a pending $535 million acquisition of Modiv Industrial, Inc. expected to close in Q3 2026, described as "immediately 4% accretive to AFFO per share" and extending weighted average lease term from 5.9 to 6.7 years; (2) completed dispositions of $145 million year-to-date including $66 million of occupied properties; and (3) a pending $18 million sale of a KPN property under contract. The Modiv acquisition is the principal disclosed event, with substantial strategic and financial implications for the REIT's portfolio composition and leverage profile.
View raw filing on EDGAR →
6-K
Legal Other
confidence 75%
filed 2026-06-29
CASI Pharmaceuticals announced settlement of an arbitration proceeding with Acrotech Biopharma regarding termination of a license agreement for exclusive commercialization rights to Evomela® in China. The settlement rescinded the purported termination and restored the License Agreement to full force and effect, subject to revised terms including minimum purchase obligations. This is a material legal resolution affecting the Company's rights to a key commercial asset, but does not fit the specific categories of material_litigation (which typically involves lawsuits filed against the registrant or government investigations) or other defined event types; it is a settlement of a contractual dispute that materially affects the Company's business operations and rights.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-06-29
Item 1.01
Theravance Biopharma entered into a definitive Agreement and Plan of Merger with Zymeworks Inc. on June 28, 2026, whereby Zymeworks will acquire Theravance for $17.00 per share in cash plus contingent value rights, representing approximately $929 million in equity value. The transaction is subject to shareholder approval and customary closing conditions, with expected close in the second half of 2026.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-29
Item 8.01
Kite Realty Group launched an offering of $300 million aggregate principal amount of exchangeable senior notes due 2032 in a private placement to qualified institutional buyers. The filing discloses the creation of a new direct financial obligation—senior unsecured exchangeable notes—which is the core definition of debt_issuance. The company intends to use proceeds to repay $300 million of existing 4.00% senior notes due 2026, refinance indebtedness, and repurchase shares, making this a material capital structure event.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-06-29
Item 1.01
Iridium Communications entered into a definitive Agreement and Plan of Merger with Rocket Lab Corporation on June 28, 2026, whereby Rocket Lab will acquire all outstanding shares of Iridium common stock for $54 per share ($27 cash plus stock consideration), representing an enterprise value of approximately $8.0 billion. The transaction is expected to close in mid-2027, subject to stockholder approval and regulatory clearance.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-06-29
Item 7.01
Terra Property Trust announced final results of a registered exchange offer in which holders of 6.00% Senior Notes due June 30, 2026 exchanged $36.2 million (66.4% of outstanding) for new 11.00% Senior Secured Notes due July 1, 2027 plus cash. This constitutes creation of a new direct financial obligation—the issuance of new debt securities—and is material to investors assessing the company's capital structure and refinancing activity, particularly given the higher coupon rate and the timing relative to the original notes' maturity.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-29
Item 2.02
This is a clear earnings release disclosing Replimune's financial results for the fiscal fourth quarter and year ended March 31, 2026. The Item 2.02 filing includes a news release (Exhibit 99.1) announcing consolidated statements of operations, balance sheet data, and detailed financial metrics including R&D expenses ($221.2M), SG&A expenses ($98.7M), and net loss ($313.9M). The disclosure is material as it provides investors with comprehensive financial performance data for the fiscal year.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-06-29
EX-99.1
Professor Duncan Murray Campbell was appointed as a director of MDJM Ltd. for a two-year term, intended to strengthen the company's professional capabilities in cultural governance and strategy.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-06-29
EX-99.2
María Consuelo Loureiro Vilarello (Chelo Loureiro) was appointed as Chief Knowledge Officer of MDJM Ltd. for an initial two-year term pursuant to an employment agreement, bringing industry credentials expected to impact the company's animation and cultural strategy.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 92%
filed 2026-06-29
The 6-K discloses entry into a Securities Purchase Agreement on June 28, 2026, for the issuance of up to $10,000,000 in Senior Convertible Notes convertible into Class A ordinary shares. The notes were issued in a private placement under Section 4(a)(2) and Regulation D, with an initial closing of $2,000,000 on June 29, 2026. This is an unregistered sale of equity securities (convertible debt) that will dilute existing shareholders upon conversion, fitting the dilutive_issuance category. The materiality is clear given the size ($10M commitment, $2M initial) and the explicit disclosure of unregistered equity issuance.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-06-29
EX-99.1
Bit Origin announced the acquisition of approximately US$11 million in NVIDIA Blackwell B300 AI infrastructure assets, consisting of 16 servers with contracted customer deployment arrangements in Malaysia expected to generate US$360,000 in monthly recurring revenue. The transaction involves a material acquisition of revenue-generating assets (US$1 million cash + US$10 million in equity via pre-funded warrants) and represents a strategic expansion into AI computing infrastructure, marking the company's first Blackwell infrastructure transaction and a key milestone in its previously announced AI infrastructure strategy.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-06-29
Item 8.01
The Board of Trustees declared a distribution of $0.22 per Common Share for June 2026, payable on or around July 20, 2026, with a record date of June 30, 2026. This is a routine but material dividend distribution to shareholders, with the option to reinvest through the Fund's distribution reinvestment plan. As a closed-end fund, regular distributions are a core component of shareholder returns and material to investor assessment.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-29
Item 5.02
The Board appointed two new directors, David Endicott and Linnea Burman, effective June 29, 2026, increasing the Board size from nine to 11 members. Both appointments include full biographical details, independence determinations, and compensation arrangements.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-06-29
EX-99.1
This exhibit is a press release announcing iHuman Inc.'s unaudited financial results for the first quarter ended March 31, 2026. It discloses quarterly revenues (RMB182.5 million), gross profit, operating loss, and net income, along with key operational metrics (MAUs) and management commentary. The document explicitly states "iHuman Inc. Announces First Quarter 2026 Unaudited Financial Results" and includes detailed financial tables and forward-looking statements typical of an earnings release. While the results show declining revenues and a shift from operating income to operating loss year-over-year, the disclosure of quarterly financial results is a material event affecting investor assessment of the registrant's performance.
View raw filing on EDGAR →
6-K
Restatement
confidence 92%
filed 2026-06-29
EX-99.1
SOL Strategies announced the filing of "amended and restated" Q2 fiscal 2026 interim financial statements that "fully replace" the original filings from May 15, 2026. The company identified and corrected multiple presentation and classification matters including revaluation loss on digital assets, earnings per share, cash flow statements, shareholders' equity changes, fair value of cryptocurrencies, stock option activity, and subsequent events. Although the company states the corrections did not change total comprehensive loss, total assets, liabilities, or shareholders' equity, the restatement of interim financial statements is a material disclosure that would affect investor assessment of financial reporting reliability.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-06-29
Item 8.01
The Board declared a distribution of $0.430 per share payable to stockholders, representing an 8.8% annualized yield. This is a routine but material capital distribution to shareholders, fitting the dividend_distribution category. The disclosure includes the per-share amount, record date, and payment date—standard elements of a dividend announcement.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-06-29
EX-99.1
This is a comprehensive technical report on the Curipamba-El Domo polymetallic project in Ecuador, prepared by SRK Consulting for Silvercorp Metals Inc. The report contains mineral resource and reserve estimates, mining and processing plans, environmental assessments, and economic analysis. While technical reports are standard industry practice for mining projects, this document discloses material operational and strategic information about the project's development status, resource base, and economic viability that would be relevant to investors assessing the company's asset base and future production potential.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-29
Item 8.01
Union Electric Company (Ameren Missouri) issued $500 million principal amount of 5.75% First Mortgage Bonds due 2056, receiving net proceeds of approximately $492.2 million. This is a material creation of a direct financial obligation through debt issuance, clearly fitting the debt_issuance category. The substantial principal amount and long-term nature of the obligation make this material to investors.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-29
EX-99.1
The exhibit discloses the closing of a non-brokered private placement of 751,445 subscription receipts at US$1.73 per receipt for aggregate gross proceeds of approximately US$1,300,000. The subscription receipts will convert into common shares and warrants upon satisfaction of escrow release conditions tied to the Drayton International acquisition. This is a classic dilutive equity issuance that increases the share count and dilutes existing shareholders, with insider participation by the CFO, COO, and a director. The materiality is evident from the capital raised and the dilutive impact on ownership percentages.
View raw filing on EDGAR →
8-K
Financial Other
confidence 72%
filed 2026-06-29
Item 1.01
The Company entered into a binding term sheet for the sale of 837 BTC (valued at $50 million) to Scilex Holding Company. While Item 1.01 typically covers M&A activity and material acquisitions/dispositions, this transaction is a cryptocurrency asset sale rather than a traditional business acquisition or merger. The sale is material (representing a significant asset disposition), but the nature—a direct asset sale of digital currency—fits more precisely under financial_other than ma_activity, which typically applies to business combinations or control changes. The substantial contingencies noted (need for definitive agreement, regulatory approvals, market conditions) and the deferred payment structure ($30M upfront, $20M over two years) underscore the transaction's financial significance.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-29
Item 5.02
Lucy Fato ceased to serve as Executive Vice President, General Counsel and Corporate Secretary effective June 25, 2026, with a final separation date of August 24, 2026. The disclosure centers on her departure from executive office and termination of employment "without cause," with associated severance payments and benefits. While she transitions to an advisory role through August, the principal disclosed action is the departure of a named executive officer from her officer positions.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-06-29
Item 1.01
The filing discloses entry into a "second amended and restated side letter" to the BANA Credit Facility on June 23, 2026, which modifies the minimum utilization level for calculating the unused commitment fee. This constitutes an amendment to an existing credit facility, a direct financial obligation. While the amendment appears technical in nature (adjusting fee calculation terms), amendments to material credit facilities are typically material to investors and fall under debt_issuance as the closest category for creation or modification of direct financial obligations.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-06-29
Item 1.01
The filing discloses entry into a "second amended and restated side letter" to the BANA Credit Facility, a revolving credit and security agreement. While this is technically an amendment rather than a new issuance, it modifies material terms of an existing direct financial obligation (the credit facility). The amendment to the minimum utilization level and unused commitment fee structure represents a modification of the credit facility's terms, which falls within the debt_issuance category's scope of "entry into or amendment of a credit facility." The materiality is supported by the fact that this is a material definitive agreement disclosed under Item 1.01.
View raw filing on EDGAR →
8-K
Financial Other
confidence 72%
filed 2026-06-29
Item 8.01
The Company reduced the available sales capacity under its ATM (at-the-market) offering from an unspecified prior amount to $5 million and suspended the Sales Agreement Prospectus effective June 29, 2026. This represents a material reduction in the Company's access to capital markets and signals potential liquidity constraints or a shift in financing strategy. While not a traditional debt issuance or dilutive equity placement, this capital-raising modification is a financial event material to investor assessment of the registrant's liquidity position.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-29
Item 2.02
AeroVironment issued a press release on June 29, 2026 announcing fourth quarter and fiscal year 2026 financial results, including record revenue of $641.6 million for Q4 and $1,976.8 million for the full year (up 133% and 141% year-over-year respectively), net income of $63.2 million for Q4, and forward guidance for fiscal 2027.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 75%
filed 2026-06-29
Item 8.01
Global Partners LP announced a full redemption of its Series B Fixed Rate Cumulative Redeemable Perpetual Preferred Units at $25.00 per unit plus accrued distributions, payable in cash on July 30, 2026. While redemption of preferred units is a capital transaction, it functions economically as a return of capital to preferred unitholders and is most closely aligned with dividend_distribution in the taxonomy. The redemption involves a cash payment to security holders and termination of their rights, which is material to investors holding or considering these securities.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 80%
filed 2026-06-29
Item 2.03
Acura received three new loans totaling $400,000 from AD Pharma (May–June 2026) under an amended secured promissory note, bringing aggregate principal to $10.7 million as of June 24, 2026, with maturity extended to December 31, 2026. The company disclosed acute financial distress, stating that without additional financing by late July 2026, it will be forced to furlough/lay off employees, terminate operations, or seek bankruptcy protection.
View raw filing on EDGAR →
8-K
Financial Other
confidence 72%
filed 2026-06-29
Item 1.02
The filing discloses termination of an at-the-market (ATM) offering agreement under Item 1.02. While the company had previously raised capital through this mechanism (2.775 million shares sold), the termination itself represents a change in the company's capital-raising capacity and signals a shift in financing strategy. This is material to investors assessing the registrant's access to capital markets, though it is not a new debt issuance, dilutive issuance, or other specifically-named financial event—hence financial_other rather than a more specific category.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-29
Item 5.07
This is a clear disclosure of shareholder voting results from Black Diamond Therapeutics' 2026 Annual Meeting held on June 26, 2026, filed under Item 5.07. The filing reports final voting tallies for four proposals: election of two Class III directors (Shannon Campbell and Kapil Dhingra), ratification of PricewaterhouseCoopers LLP as auditor, advisory approval of named executive officer compensation, and determination of voting frequency for future compensation advisory votes. The disclosure includes vote counts (FOR, AGAINST, ABSTAIN, BROKER NON-VOTES) for each proposal, making this a textbook shareholder_vote_results event.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-06-29
Item 8.01
The disclosure announces FDA authorization of an Investigational New Drug (IND) application for GT-02287, enabling the company to initiate Phase 2 clinical development in Parkinson's disease. This is a material regulatory milestone in the drug development pipeline that would affect a reasonable investor's assessment of the company's progress and prospects, but does not fit the specific categories of earnings, M&A, impairment, litigation, or other named event types. It is clearly an operational/strategic business milestone.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-29
Item 1.01
Hertz Corp. completed an offering of $350 million aggregate principal amount of 6.75% Exchangeable Senior First-Lien Secured PIK Notes due 2030 pursuant to an Indenture dated June 29, 2026. This represents a material creation of a new direct financial obligation with specified interest rates, maturity date, exchange features, and covenants.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-29
Item 3.02
Hertz issued Exchangeable Notes in a private placement under Section 4(a)(2) and Rule 144A to qualified institutional buyers, with a maximum of 148.2 million shares of Common Stock potentially issuable upon exchange (or 169.4 million if the greenshoe is exercised). This unregistered offering of convertible securities materially affects shareholder equity and voting power.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-29
Item 8.01
Hertz entered into an underwriting agreement on June 24, 2026 for the public offering of 37,037,037 shares of Common Stock at $2.70 per share, with shares loaned to J.P. Morgan Securities LLC under a share lending agreement. This registered public offering on Form S-3 represents a material equity issuance that dilutes existing shareholders.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-29
Item 7.01
Cogent Communications completed the sale of 10 data center facilities to an I Squared Capital affiliate for $225 million in cash on June 29, 2026. This is a material disposition of assets—a significant divestiture of operating facilities that would affect a reasonable investor's assessment of the company's asset base, revenue-generating capacity, and capital structure. The transaction was previously announced and closed on the filing date, making this a completion of a material M&A activity.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-29
Item 5.07
United Therapeutics held its Annual Meeting of Shareholders on June 26, 2026, with shareholders voting on four matters: election of 11 directors, advisory vote on executive compensation, approval of the 2026 Stock Incentive Plan, and ratification of Ernst & Young LLP as independent auditor. The filing discloses the detailed vote tallies for each matter.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-06-29
Item 1.01
Liberty Capital Corp entered into Amendment No. 1 to its Credit Agreement on June 29, 2026, adding $455 million in new incremental debt facilities comprising a $155 million delayed draw Term A-1 Loan, a $300 million Term A-2 Loan, and a $25 million incremental revolving L/C facility, all secured by substantially all assets of GCI and its subsidiaries.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 97%
filed 2026-06-29
Item 5.07
TopBuild stockholders voted on June 29, 2026 to approve the merger agreement with QXO, with approximately 78% of votes cast (65% of outstanding shares) voting in favor of the TopBuild Merger Proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 97%
filed 2026-06-29
Item 5.07
QXO and TopBuild stockholders voted on the proposed acquisition on June 29, 2026. QXO stockholders approved the issuance of QXO common stock as consideration (~99% in favor) and a charter amendment to increase authorized shares from 2 billion to 4 billion (~99.2% in favor); TopBuild stockholders approved the merger agreement (78% of votes cast, 65% of outstanding shares).
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-29
Item 1.01
FS KKR Capital Corp. issued and sold 6,000,000 shares of Cumulative Convertible Perpetual Preferred Stock to KKR Alternative Assets L.P. for $150 million on June 29, 2026. The convertible preferred stock is convertible into common stock at an initial conversion price of $18.83 per share, creating material dilution potential for existing common shareholders.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-06-29
Item 8.01
The company's investment adviser waived 50% of subordinated income incentive fees for four fiscal quarters (Q2 2026 through Q1 2027) with no recoupment rights, materially reducing the company's operating costs during the waiver period.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-06-29
Item 5.02
The filing discloses compensatory arrangements for three named executives: salary increases (retroactive to April 1, 2026) for Serhii Kupriienko (CEO Global) from $250,000 to $375,000, Alexander Fink (CEO U.S. and President) from $250,000 to $375,000, and Brooks Ensign (CFO) from $250,000 to $300,000, along with target annual bonuses of 100%, 100%, and 50% of base salary respectively. These are material changes to executive compensation approved by the Compensation Committee and Board.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-29
Item 7.01
This Item 7.01 disclosure concerns the proposed business combination between Spring Valley Acquisition Corp. III (SVAC) and General Fusion Inc., which was previously disclosed in an 8-K filed January 23, 2026. The filing furnishes an updated investor presentation (Exhibit 99.1) for use in shareholder presentations. The disclosure references the Business Combination Agreement, the effective Registration Statement on Form F-4 (declared effective June 12, 2026), and the definitive Proxy Statement filed June 15, 2026 for shareholder voting. This is a material acquisition/change-of-control transaction in the advanced stages of completion, with shareholder voting imminent.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-29
Item 1.01
Angel Studios entered into amended and restated merger agreements on June 29, 2026 to acquire two production companies: Tuttle Twins Show, LLC and Toothy Cow Productions, LLC. The filing discloses material revisions to previously disclosed merger agreements, including extended closing dates (October 31, 2026), modified closing conditions, and clarified consideration structures. The Company has already committed $11.7 million in operational funding to TTS and $11.9 million to TCP, with significant insider ownership stakes (41.6% of TTS units and 2.4% of TCP units held by Company-related parties). These are material acquisition transactions that would substantially affect the registrant's business and financial position.
View raw filing on EDGAR →